Wenyao Mak

12PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPsychosocial aspects of childbirth and perinatal mental healthPharmaceutical delivery technologiesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 25, 2026
Real-World Pharmacokinetic and Exposure-Response Characterization of Venetoclax in Chinese Patients with Hematological Malignancies.

Zhirui Liu, Xin Liu, Qiang Gong

|Mar 23, 2026
Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19.

Akosua A Agyeman, Laura Buggiotti, Li-An K Brown

|Dec 21, 2025
Population Time-to-Event Modeling of Pregnancy Loss Risk Following Frozen Embryo Transfer: A Real-World Study in Chinese Women.

Wen Yao Mak, Muyesaier Alifu, Aole Zheng

|Nov 12, 2025
Reference range of rivaroxaban-calibrated anti-Xa activity in Chinese children with giant coronary artery aneurysms after KawasakI disease: insights from a population pharmacokinetic and pharmacodynamic analysis.

Bijue Liu, Guang-An Dai, Nuo Xu

|Feb 19, 2025
PBPK Modeling: Empowering Drug Development and Precision Dosing in China.

Dongsheng Yang, Jian Li, Wen Yao Mak

|Jan 29, 2025
Population pharmacokinetics and pulmonary modeling of eravacycline and the determination of microbiological breakpoint and cutoff of PK/PD.

Xi-Wei Ji, Wen Yao Mak, Feng Xue

Pageof 2

Frequent Collaborators

7 joint publications

Xiao Zhu

7 joint publications

Xiaoqiang Xiang

6 joint publications

Qingfeng He

3 joint publications

Zhijia Tang